Prashant Soni, MD
Plastic Surgery · Danbury, CTNPI 1003969056
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 29.0% of the total. That places this record below the midpoint for plastic surgery clinicians in CT, where the typical reported total is $989.
Across 43 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$259
- Mentor Worldwide LLC$86
- AstraZeneca$60
- Smith+Nephew$53
- LEO Pharma Inc.$39
- Acelrx Pharmaceuticals, Inc.$37
- plus $361 from 17 others
What the payments were for
- Food & beverage$895100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $259 |
| Mentor Worldwide LLC | 2 | $86 |
| AstraZeneca(2 entities) | 3 | $60 |
| Smith+Nephew | 2 | $53 |
| LEO Pharma Inc. | 2 | $39 |
| Acelrx Pharmaceuticals, Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $34 |
| TELA Bio, Inc. | 1 | $33 |
| GSK | 1 | $26 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 2 | $24 |
| Eisai Inc. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Kerecis Limited | 1 | $19 |
| Endo USA, Inc. | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $18 |
| Lifenet Health | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Biofrontera Inc. | 1 | $17 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $16 |
| Sanara Medtech Inc. | 1 | $15 |
How this compares
$895 in reported general payments places this provider in the 45th percentile of 62 plastic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $173 |
| Cefadroxil | 78 | $159 |
| Oxycodone Hcl | 36 | $117 |
| Cephalexin | 26 | $86 |
| Silver Sulfadiazine | 12 | $57 |
| Clindamycin Hcl | 16 | $44 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Danbury
- Sameer MassandDanbury$3K
- Mohammad IslamDanbury$2K
- Amir NasirDanbury$1K
- David GoldenbergDanbury$226
- Michael AlperovichNew Haven$78K
- Derek SteinbacherGuilford$59K
- Siba HaykalNew Haven$45K
- Wilfred BrownMiddlebury$34K
- Beth CollinsGuilford$29K
- Stephen BrownHartford$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.